| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Neogenomics, Inc. (NEO) have been net sellers, shedding 20,000 shares worth roughly $321K on balance.
NEO sits in the Life Sciences Tools & Services industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 220.0K | - | - | |
| COO | 191.7K | - | - | |
| CEO | 133.1K | - | - | |
| VP | 90.9K | - | - | |
| Dir | 86.1K | $955.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2024 | Olivo Alicia C69 | General Counsel | Sell10b5-1 | 2,587 | $14.96 | $38,712.90 | -6.9% | +1.5% | -3.2% | |
| Nov 17, 2023 | Olivo Alicia C69 | General Counsel | Sell10b5-1 | 2,669 | $18.39 | $49,082.91 | -6.7% | -23.2% | -22.5% | |
| Mar 7, 2022 | Bonello William | Chief Financial Officer | Sale+OE | 3,209 | $18.29 | $58,692.61 | -3.2% | -55.7% | +0.6% | |
| Dec 21, 2021 | McKenzie Kathryn B | Chief Financial Officer | Sale+OE | 1,846 | $35.00 | $64,610.00 | -13.6% | -50.7% | -72.2% | |
| Dec 6, 2021 | Mallon Mark | Chief Executive Officer | Buy | 17,000 | $30.63 | $520,710.00 | +30.5% | -43.0% | -63.4% | |
| Nov 26, 2021 | Brown Douglas Matthew79 | Chief Strategy Officer | Sell | 100,000 | $36.96 | $3,695,999.89 | -89.6% | -43.2% | -72.0% | |
| Nov 24, 2021 | Bonello William | President, Informatics | Sale+OE | 25,000 | $37.13 | $928,250.00 | -61.8% | -50.3% | -72.7% | |
| Jun 8, 2021 | Crowther Bruce K | Director | Sale+OE | 20,734 | $41.46 | $859,631.64 | -29.5% | +23.4% | -79.6% | |
| Jun 3, 2021 | Cardoza George | President, Pharma Services | Sell | 200,337 | $40.35 | $8,082,901.47 | -53.1% | +25.3% | -79.9% | |
| May 25, 2021 | Shovlin Robert J. | President, Clinical Services | Sale+OE | 130,604 | $39.31 | $5,134,043.24 | -46.5% | +13.9% | -79.9% |